-
Professor Zhang Xiaohui: In ALL, is the immunotherapy era an opportunity or a challenge for allo-HSCT?
Time of Update: 2021-04-23
The ECOG2993 study showed that the efficacy of sibling allo-HSCT in standard-risk PH-ALL patients is better than autologous hematopoietic stem cell transplantation and traditional chemotherapy, and the 5-year OS rate is better (62% vs 52%).
-
China FORWARD | my country's original third-generation EGFR-TKI postoperative adjuvant treatment key registration phase III clinical study starts
Time of Update: 2021-04-23
094) published the full online phase IIb clinical study of vometinib in the treatment of patients with EGFR T790M mutation in advanced NSCLC (NCT03452592) Results: Among 220 subjects enrolled in the Phase IIb study, the objective response rate (ORR) of 80 mg vomitinib reached 74%, the disease control rate (DCR) reached 94%, and the median progression-free survival The period (PFS) is 9.
-
Prof. Yingying Xu: From population selection to plan formulation, "re-understanding" of neoadjuvant treatment for breast cancer | 2021 CSCO BC
Time of Update: 2021-04-23
In addition, based on the results of the KATHERINE study, St Gallen experts support all HER2+ tumors with residual lesions after standard neoadjuvant treatment, even patients with residual invasive tumors less than 5 mm should receive adjuvant T-DM1 treatment.
-
99% of cervical cancers are related to TA!
Time of Update: 2021-04-23
Professor Zhou Qi talks with patients with cervical small-cell neuroendocrine cancer, from recurrence prevention to treatment of adverse reactions of radiotherapy and chemotherapy.
-
Professor Han Weidong’s team issued a paper: The total remission rate reached 95%, and decitabine combined with PD-1 significantly improved the clinical outcome of patients with classic Hodgkin’s lymphoma | Yimai Meng broke the news
Time of Update: 2021-04-23
Recently (April 5, 2021), the Journal for ImmunoTherapy of Cancer (JITC) published online a clinical research paper by Professor Han Weidong’s team at the PLA General Hospital, entitled "Improved clinical outcome in a randomized phase II study" of anti-PD-1 camrelizumab plus decitabine in relapsed/refractory Hodgkin lymphoma".
-
Express | Innovative first-line therapy for gastric cancer is recognized as a breakthrough therapy by FDA, Zai Lab owns rights in Greater China
Time of Update: 2021-04-23
▎The content team editor of WuXi AppTec today, Amgen announced that the US FDA granted its research FGFR2b antibody therapy bemarituzumab breakthrough therapy designation, combined with chemotherapy, for the first-line treatment of HER2-negative locally advanced or metastatic gastric cancer And gastroesophageal junction (GEJ) cancer patients.
-
The first adjuvant therapy for early lung cancer: AstraZeneca's EGFR-targeting drug Tagrisso was approved in China
Time of Update: 2021-04-23
This is the third indication that Teresa has been approved in China, and it is also another important achievement of this product as an adjuvant therapy for lung cancer after it was approved in the United States in December last year for the adjuvant treatment of early-stage EGFR-mutant lung cancer patients.
-
Big data of 3.5 million people reveal that obesity is associated with the risk of 26 cancers
Time of Update: 2021-04-23
5 million people showed that obese people with a higher body mass index (BMI) have an increased risk of 12 cancers, and among non-smokers, BMI is also positively correlated with the risk of blood cancer and head and neck cancer.
-
Why does the risk of colorectal cancer increase?
Time of Update: 2021-04-23
A new study recently published in the journal Clinical Nutrition reveals that a type of food is associated with an increased risk of colorectal cancer.
Researchers analyzed that the association between eating ultra-processed foods and increased risk of colorectal cancer may be related to many reasons.
-
Top 10 questions that patients with pancreatic cystic tumors most want to know |
Time of Update: 2021-04-23
Professor Xu Xiaowu: In terms of surgical operation methods, traditional pancreatic surgery focuses on open surgery, but minimally invasive surgery such as laparoscopic surgery and robotic surgery has developed rapidly in the past 20 years.
-
National Cancer Prevention and Treatment Week | Big coffee experts talk about the current status and latest progress of gastrointestinal cancer prevention and treatment
Time of Update: 2021-04-22
Pancreatic cancerCurrently, under the leadership of Professor Li Jin, the Oncology Department of Shanghai Oriental Hospital is cooperating with Boehringer Ingelheim to conduct a global clinical study on KRAS mutant colorectal cancer.
-
A rising star in cancer immunotherapy-γδ T cells
Time of Update: 2021-04-22
com/tags/%E8%AF%BA%E5%8D%8E/">NovartisThe bispecific antibody developed by Lava, which binds to tumor cells on one side and γδ T cells on the other, can redirect the patient's own γδ T cells and other immune cells (such as natural killer cells) to tumor targets.
-
American Journal of Clinical Nutrition: Can eating beef reduce the risk of heart disease?
Time of Update: 2021-04-22
do?w=%E5%BF%83%E8%A1%80%E7%AE%A1">heart blood vessels eating Mediterranean diet low in saturated fat, and 500g / week unprocessed lean red meat, five weeks later, can lower total cholesterol and low-density lipoprotein cholesterol (LDL-c), we all know that high levels of LDL -c is an independent risk factor for atherosclerosis.
-
JCO: The 5-year prognosis of first-line pembrolizumab for patients with metastatic NSCLC is significantly better than chemotherapy!
Time of Update: 2021-04-22
This article reports the first 5-year follow-up results of the phase III trialIn this trial, patients were randomly assigned to the pembrolizumab group (200 mg, 1 time/3 weeks, for 35 courses) or platinum-based chemotherapy group at 1:1 ratio.
-
Int J Cancer: The addition of high-risk HPV testing to cytology can detect pre-invasive cervical lesions earlier
Time of Update: 2021-04-22
Infection screening Recently, researchers conducted a prospective randomized controlled trial and conducted two rounds of screening to evaluate the effect of HPV testing and body fluid cytology (LBC) combined testing and LBC alone in cervical cancer screening in the Chinese population.
-
Lancet Public Health: Global risk estimation of cervical cancer for girls born between 2005 and 2014
Time of Update: 2021-04-22
Globally, without vaccination, the burden of cervical cancer in this study cohort is expected to reach 116 million cases in 2094.
-
O Drug New Surprise: US FDA Approves Immunotherapy for First-line Treatment of Advanced Gastric Cancer for the First Time
Time of Update: 2021-04-22
April 16, the US Food and Drug Administration Bureau ( the FDA when) the approval of Bristol-Myers Squibb PD-1 monoclonal antibody inhibitors Carolina Wu (Opdivo, nivolumab) with certain types of chemotherapy used in combination, for advanced or metastaticInitial treatment of patients with gastric cancer , gastroesophageal junction cancer and esophageal adenocarcinoma.
-
my country releases ``Recommendations for the Screening and Prevention of Common Malignant Tumors among Residents'' in 2021
Time of Update: 2021-04-22
The Shanghai Anti-Cancer Association and Fudan University Cancer Hospital publish the "Recommendations for Common Residents' Screening and Prevention of Malignant Tumors" every year to provide guidance for individuals, families and society in cancer prevention.
-
Brit J Cancer: The relationship between endogenous hormones and the risk of invasive breast cancer in premenopausal and postmenopausal women
Time of Update: 2021-04-22
Endogenous hormones and risk of invasive breast cancer in pre- and post-menopausal women: findings from the UK Biobank .
021-01392-zEndogenous hormones and risk of invasive breast cancer in pre- and post-menopausal women: findings from the UK Biobank in this message
-
National Cancer Prevention and Treatment Week: The availability of medicines is further improved, and the burden on patients is greatly reduced
Time of Update: 2021-04-22
1. China urgently needs to increase awareness of family cancer prevention and control1.
com/tags/%E4%B9%B3%E8%85%BA%E7%99%8C/">breast cancer surpassed lung cancer as the most common cancer in the world for the first time; lung cancer, bioon.
